Bastex SRL
1.8 FTEThe score of Bastex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets 0 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bastex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 02 Sep 2022
Bastex's financial analysis
- Solvency59.5%sector median: 51.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bastex
Bastex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0733.645.345
- VAT number
- BE0733645345
- Peppol
- Registered · 0208:0733645345 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Sep 2019
- Registered office
- 4624 Fléron
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
Bastex (SRL) has been based in Fléron since 2019, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net profit of 486,338 € and equity of €1.18m; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 59.5%, above the median of its sector (51.2%).
Companies similar to Bastex
Companies in the same business, of comparable size and area, outside its group.
- Cabinet Medical D'Expertise Willems All other professional, scientific and technical activities n.e.c. Ferrières · balance sheet 345,830 €
- Docteur Blaise Pierre General medical practice activities Verviers · balance sheet €2.56m
- Medisch kabinet Dr. Temmerman Tom General medical practice activities Berlare · balance sheet €1.54m
- Dr. Steven Ceulemans General medical practice activities Hasselt · balance sheet 409,084 €
- DOKTER de MuELENAERE FRANCIS General medical practice activities Ardooie · balance sheet 565,723 €
- Cabinets Medicaux ET Expertises Graide General medical practice activities Bièvre · balance sheet 771,362 €
- Dokters Ceulemans & DE Doncker General medical practice activities Rijkevorsel · balance sheet 684,699 €
- DR. VAN NUFFEL, huisarts General medical practice activities Rotselaar · balance sheet €1.27m
Frequently asked questions about Bastex
What is the revenue of Bastex?
Bastex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bastex?
In Belgium, the VAT number is the company number prefixed with BE: BE0733645345 for Bastex, if the company is VAT-registered. Its company number (CBE) is 0733.645.345.
Where is the registered office of Bastex?
According to the CBE register, the registered office of Bastex is in 4624 Fléron.
What is the equity of Bastex?
At the close of the 2025 financial year, the equity of Bastex amounts to 1,176,010 €, a solvency of 59.5% of total assets.
How many people work at Bastex?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bastex?
The register lists 1 active mandates at Bastex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bastex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →